Related references
Note: Only part of the references are listed.Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma
Se Ryeong Jang et al.
JAMA NETWORK OPEN (2021)
The impact of sex and gender on immunotherapy outcomes
Sabra L. Klein et al.
BIOLOGY OF SEX DIFFERENCES (2020)
Strength of immune selection in tumors varies with sex and age
Andrea Castro et al.
NATURE COMMUNICATIONS (2020)
A step by step guide for conducting a systematic review and meta-analysis with simulation data
Gehad Mohamed Tawfik et al.
TROPICAL MEDICINE AND HEALTH (2019)
Correlation between sex and efficacy of immune checkpoint inhibitors (PD-1 and CTLA-4 inhibitors)
Yingcheng Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Andrea C. Tricco et al.
ANNALS OF INTERNAL MEDICINE (2018)
Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune system
Fabio Conforti et al.
Oncotarget (2018)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The sexist behaviour of immune checkpoint inhibitors in cancer therapy?
Andrea Botticelli et al.
ONCOTARGET (2017)
Sex differences in immune responses
Sabra L. Klein et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Guidance for conducting systematic scoping reviews
Micah D. J. Peters et al.
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)
Sex Disparities in Cancer Mortality and Survival
Michael B. Cook et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Sex bias in neuroscience and biomedical research
Annaliese K. Beery et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Scoping studies: advancing the methodology
Danielle Levac et al.
IMPLEMENTATION SCIENCE (2010)
Share Paper
